ComplyRx

Respiratory · Live ClinicalTrials.gov data

Nerandomilast clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 nerandomilast trials on ClinicalTrials.gov by enrolment, 10 of them actively recruiting. The next phase 3 primary completion among them is expected Apr 2027. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

10

Phase 3 trials

10

Actively recruiting

Apr 2027

Next phase 3 primary completion

7,173

Participants across trials

Boehringer Ingelheim

Lead sponsor by trial count

nerandomilast (16)14 active2022–2031
nerandomilast
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingNot yet recruitingCompleted
'22
'23
'24
'25
'26
'27
'28
'29
'30
'31
nerandomilast
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)P3
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)P3
CONQUESTP2
FIBRONEER™-ONP3
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)P2
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic DiseasesP3
MERCURION-IPFP3
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisP2
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary FibrosisP3
ARGiNAUTP2
NERAM-PFP4
This Study Evaluates the Safety, Target Engagement, and Preliminary Efficacy of Galunisertib (TGF-βR1/ALK5 Inhibitor)Combined With Nerandomilast (PDE4 Inhibitor) in GREM2-positive ALS, a Biomarker-defined Subgroup Hypothesized to Reflect Heightened TGF-β/SMAD-driven Astrocytic and Fibrotic SignalingP2
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)P3
VERANDA™-SScP3
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease ProgressionP3
VERANDA™-IIMP3

Upcoming readouts

14 ahead · nerandomilast

Select a trial to load its full ClinicalTrials.gov record.

Key nerandomilast trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

TrialTitlePhaseStatusPrimary completion
NCT07570888NERAM-PF: This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across …Phase 4Not yet recruitingJun 2027
NCT06238622FIBRONEER™-ON: A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibros…Phase 3RecruitingApr 2027
NCT06806592A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseas…Phase 3RecruitingJul 2027
NCT07299695MERCURION-IPF: Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibr…Phase 3RecruitingJun 2028
NCT07366034A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Childre…Phase 3RecruitingApr 2029
NCT07201922A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Fa…Phase 3RecruitingMay 2029
NCT07497087VERANDA™-SSc: A Study to Test Whether Nerandomilast Helps People With Systemic SclerosisPhase 3RecruitingFeb 2030
NCT07540988FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lu…Phase 3Not yet recruitingDec 2028
NCT07789015VERANDA™-IIM: A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myop…Phase 3Not yet recruitingMar 2030
NCT05321069A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonar…Phase 3CompletedAug 2024
NCT05321082A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosi…Phase 3CompletedDec 2024
NCT06195072CONQUEST: Platform Clinical Study for Conquering SclerodermaPhase 2RecruitingNov 2026

Track nerandomilast with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track nerandomilast

Related drug pipelines

Compare nerandomilast vs tezepelumab

FAQ

How many clinical trials are running for nerandomilast?
ClinicalTrials.gov lists more than 16 phase 2–4 nerandomilast trials. This page tracks the 16 largest by enrolment: 5 phase 2, 10 phase 3, and 1 phase 4 among them, with 10 actively recruiting. Updated daily.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare nerandomilast against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.